Greater Glasgow and Clyde Medicines

Medicines Update

For all healthcare professionals across NHSGGC both in primary care and the acute sector.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.

06/09/2023 announcement

Accessing GGC Clinical Guidelines via Medicines Update blogs and the Adult Therapeutics Handbook 

GGC Clinical Guidelines have migrated to the Right Decisions for Health and Care platform. As a result of the migration, direct links to GGC guidelines within Medicines Update blogs (and the Adult Therapeutics Handbook, GGC Medicines App) currently go to the homepage and not individual guidelines. This change was out with our control. 
Please note, there is a message on the homepage highlighting intermittent issues with the search function, therefore, if you cannot find a guideline via the search box, select the relevant category from the homepage or if the guideline still can't be found, contact
An update will be provided in due course.

Transdermal opioids

Posted: Friday, December 1, 2023

Category - Medicines Update

General key messages

  • Opioid patches are only suitable for stable pain and in certain circumstances (see below)
  • Fentanyl patches are not suitable for opioid naïve patients due to their potency
  • As transdermal opioid preparations are not interchangeable, patients should remain on the same preparation, prescribed by brand name
  • Where specified brand is not available, to avoid missed doses, an alternative brand can be considered. Monitor closely for loss of pain control/opioid toxicity



MyPsych has a new home!

Posted: Monday, November 27, 2023

Category - Medicines Update

Key messages:

  • MyPsych has moved to NHS Scotland Right Decisions platform
  • Effective from 1st November 2023
  • Users are required to download new app to continue to access content

High-Cost Liquid Medicines in Adults - an update

Posted: Friday, November 17, 2023

Category - Medicines Update

Key Messages:

  • Liquid medications incur additional costs compared to other solid dosage formulations and for the majority of adult patients with swallowing difficulties, liquid formulations are not required
  • Excipients in liquid medications such as sorbitol often cause GI side-effects and the effects can be cumulative in patients prescribed multiple liquids
  • If a liquid medication is prescribed and/or supplied due to an issue sourcing solid dosage formulations, this should be reviewed as soon as the solid dosage formulation is available

Key Medicine Shortages – November 2023

Posted: Monday, November 13, 2023

Category - Medicines Update

Key Medicine Shortages October 2023 here


Bisacodyl (Dulcolax®) 5mg suppositories, Bumetanide 1mg and 5mg tablets, Lamotrigine 5mg dispersible tablets, Pancreatin (Pancrease® HL) gastro-resistant tablets and Testosterone enantate 250mg/ml solution for injection ampoules.


Dual Antiplatelet Therapy with Prasugrel following Percutaneous Coronary Intervention

Posted: Tuesday, November 7, 2023

Category - Medicines Update

Key messages:

  • Following discussion at the West of Scotland Cardiology Prescribing Group, the decision has been made to change to prescribing of prasugrel in the majority of future patients undergoing percutaneous coronary intervention (PCI)

  • Prasugrel will replace ticagrelor, in combination with aspirin, as the dual antiplatelet therapy (DAPT) agent of choice post-PCI for the majority of patients from Monday 06th November 2023


NSAID – Guideline update

Posted: Wednesday, November 1, 2023

Category - Medicines Update

NSAID – Guideline update here

The NHSGGC guideline Oral Non-Steroidal Anti-Inflammatory (NSAID) has been updated.

Summary of Changes

As per NICE Clinical Knowledge Summary (CKS):

• Risk of NSAID-induced GI adverse events (AEs) now categorised as low, moderate or high risk.
• Further information added on how to define GI risk factors.
• COX-2 inhibitors (celecoxib and etodolac) in combination with a PPI added as a treatment option for patients at high risk of GI AEs.
• Ibuprofen dosing advice changed (as per BNF maintenance dose).
• Prescribing notes updated to include sick day rules and prescribing guidance for COX-2 inhibitors.